Observational studyBMC nephrology2025

Plasma monocyte chemoattractant protein-1 and the risk of kidney and cardiovascular outcomes in people with chronic kidney disease: results from the BRIGHTEN study.

Tadashi Toyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.